vs
Adeia Inc.（ADEA）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是Adeia Inc.的1.2倍（$127.1M vs $104.8M），Adeia Inc.同比增速更快（19.5% vs 17.1%），过去两年再鼎医药的营收复合增速更高（20.8% vs 9.5%）
Adeia Inc.是一家全球化知识产权授权与创新企业，主营半导体制造、消费电子、媒体分发及智能设备领域的专利技术研发与商业化合作，与全球多家头部科技企业达成授权合作，推动相关行业技术升级。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
ADEA vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.2倍
$104.8M
营收增速更快
ADEA
高出2.4%
17.1%
两年增速更快
ZLAB
近两年复合增速
9.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.8M | $127.1M |
| 净利润 | $22.8M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 33.2% | -54.6% |
| 净利率 | 21.7% | — |
| 营收同比 | 19.5% | 17.1% |
| 净利润同比 | 92.8% | — |
| 每股收益（稀释后） | $0.20 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADEAZLAB
| Q1 26 | $104.8M | — | ||
| Q4 25 | $182.6M | $127.1M | ||
| Q3 25 | $87.3M | $115.4M | ||
| Q2 25 | $85.7M | $109.1M | ||
| Q1 25 | $87.7M | $105.7M | ||
| Q4 24 | $119.2M | $108.5M | ||
| Q3 24 | $86.1M | $101.8M | ||
| Q2 24 | $87.3M | $100.1M |
净利润ADEAZLAB
| Q1 26 | $22.8M | — | ||
| Q4 25 | $73.7M | — | ||
| Q3 25 | $8.8M | $-36.0M | ||
| Q2 25 | $16.7M | $-40.7M | ||
| Q1 25 | $11.8M | $-48.4M | ||
| Q4 24 | $36.0M | — | ||
| Q3 24 | $19.3M | $-41.7M | ||
| Q2 24 | $8.4M | $-80.3M |
毛利率ADEAZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% |
营业利润率ADEAZLAB
| Q1 26 | 33.2% | — | ||
| Q4 25 | 59.5% | -54.6% | ||
| Q3 25 | 30.9% | -42.3% | ||
| Q2 25 | 19.1% | -50.3% | ||
| Q1 25 | 26.0% | -53.3% | ||
| Q4 24 | 48.2% | -62.6% | ||
| Q3 24 | 32.7% | -66.6% | ||
| Q2 24 | 27.1% | -76.0% |
净利率ADEAZLAB
| Q1 26 | 21.7% | — | ||
| Q4 25 | 40.4% | — | ||
| Q3 25 | 10.1% | -31.2% | ||
| Q2 25 | 19.5% | -37.3% | ||
| Q1 25 | 13.5% | -45.8% | ||
| Q4 24 | 30.2% | — | ||
| Q3 24 | 22.4% | -40.9% | ||
| Q2 24 | 9.6% | -80.2% |
每股收益（稀释后）ADEAZLAB
| Q1 26 | $0.20 | — | ||
| Q4 25 | $0.66 | $-0.05 | ||
| Q3 25 | $0.08 | $-0.03 | ||
| Q2 25 | $0.15 | $-0.04 | ||
| Q1 25 | $0.10 | $-0.04 | ||
| Q4 24 | $0.32 | $-0.09 | ||
| Q3 24 | $0.17 | $-0.04 | ||
| Q2 24 | $0.07 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $53.3M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $715.5M |
| 总资产 | $1.0B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ADEAZLAB
| Q1 26 | $53.3M | — | ||
| Q4 25 | $136.7M | $689.6M | ||
| Q3 25 | $115.1M | $717.2M | ||
| Q2 25 | $116.5M | $732.2M | ||
| Q1 25 | $116.5M | $757.3M | ||
| Q4 24 | $110.4M | $779.7M | ||
| Q3 24 | $89.2M | $616.1M | ||
| Q2 24 | $94.5M | $630.0M |
总债务ADEAZLAB
| Q1 26 | — | — | ||
| Q4 25 | $418.5M | — | ||
| Q3 25 | $438.7M | — | ||
| Q2 25 | $448.9M | — | ||
| Q1 25 | $459.2M | — | ||
| Q4 24 | $475.5M | — | ||
| Q3 24 | $524.4M | — | ||
| Q2 24 | $535.6M | — |
股东权益ADEAZLAB
| Q1 26 | — | — | ||
| Q4 25 | $480.5M | $715.5M | ||
| Q3 25 | $413.7M | $759.9M | ||
| Q2 25 | $402.9M | $791.7M | ||
| Q1 25 | $389.5M | $810.8M | ||
| Q4 24 | $396.6M | $840.9M | ||
| Q3 24 | $378.2M | $667.7M | ||
| Q2 24 | $359.1M | $704.2M |
总资产ADEAZLAB
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $1.1B | $985.3M | ||
| Q2 24 | $1.1B | $987.4M |
负债/权益比ADEAZLAB
| Q1 26 | — | — | ||
| Q4 25 | 0.87× | — | ||
| Q3 25 | 1.06× | — | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 1.18× | — | ||
| Q4 24 | 1.20× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | 1.49× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.5M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 2.57× | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流ADEAZLAB
| Q1 26 | $58.5M | — | ||
| Q4 25 | $60.0M | $-26.0M | ||
| Q3 25 | $17.8M | $-32.0M | ||
| Q2 25 | $23.1M | $-31.0M | ||
| Q1 25 | $57.1M | $-61.7M | ||
| Q4 24 | $107.5M | $-55.8M | ||
| Q3 24 | $14.3M | $-26.8M | ||
| Q2 24 | $23.5M | $-42.2M |
自由现金流ADEAZLAB
| Q1 26 | — | — | ||
| Q4 25 | $59.4M | $-26.7M | ||
| Q3 25 | $17.0M | $-35.0M | ||
| Q2 25 | $22.9M | $-33.9M | ||
| Q1 25 | $56.9M | $-63.2M | ||
| Q4 24 | $106.9M | $-58.4M | ||
| Q3 24 | $14.3M | $-28.2M | ||
| Q2 24 | $23.0M | $-42.9M |
自由现金流率ADEAZLAB
| Q1 26 | — | — | ||
| Q4 25 | 32.5% | -21.0% | ||
| Q3 25 | 19.5% | -30.4% | ||
| Q2 25 | 26.7% | -31.1% | ||
| Q1 25 | 64.9% | -59.9% | ||
| Q4 24 | 89.7% | -53.8% | ||
| Q3 24 | 16.6% | -27.7% | ||
| Q2 24 | 26.4% | -42.9% |
资本支出强度ADEAZLAB
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.9% | 2.6% | ||
| Q2 25 | 0.2% | 2.6% | ||
| Q1 25 | 0.3% | 1.5% | ||
| Q4 24 | 0.5% | 2.4% | ||
| Q3 24 | 0.1% | 1.3% | ||
| Q2 24 | 0.5% | 0.7% |
现金转化率ADEAZLAB
| Q1 26 | 2.57× | — | ||
| Q4 25 | 0.81× | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 1.38× | — | ||
| Q1 25 | 4.84× | — | ||
| Q4 24 | 2.98× | — | ||
| Q3 24 | 0.74× | — | ||
| Q2 24 | 2.80× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADEA
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
